|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Ignyta Appoints Jerry Hurst to Executive Advisory Board
2/15/2013 9:14:57 AM
SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, announced today the appointment of Jerry Hurst, a veteran of CLIA lab operations and former manger of the state of California’s CLIA lab inspection program, to its Executive Advisory Board. “As Ignyta prepares to establish a leading CLIA lab to perform diagnostic services for autoimmune disease, we are assembling a team with proven track records in successful laboratory development, licensure and operations,” said Jonathan Lim, M.D., co-founder, chairman and CEO of Ignyta. “With over 30 years of experience in clinical laboratory science, including as manager of the state of California’s CLIA inspection program, and his subsequent involvement in the establishment of multiple commercial CLIA labs, Jerry has an unmatched understanding of what is required to successfully develop and operate a CLIA lab.”
|
|
|
|
|
|
|
|
|
|
|